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Abstract
Background Children who present with idiopathic slip-
ped capital femoral epiphysis (SCFE) have an increased
risk of developing bilateral disease. Predicting which
patients will develop problems with bilateral hips is
important for determining treatment algorithms. This is a
retrospective observational study that evaluates the rela-
tionship and risk between body mass index (BMI)-for-age
and unilateral and bilateral SCFE in patients followed until
physeal closure.
Methods This is a retrospective study of all patients with
SCFE presenting to one institution from 1998–2005. Using
the Center for Disease Control (CDC) references, BMI-for-
age was calculated for each patient. The patients were
followed up until complete closure of the bilateral proximal
femoral physes, which was considered completion of the
study. Statistical analysis for significant differences
between groups was performed using the Kruskal–Wallis
test for equality of populations. A logistic regression,
controlling for age and gender, was used to identify BMI-
for-age as a risk factor and to determine the significance of
the odds ratios (ORs) for the relevant categorical vari-
ables—obese, overweight and healthy weight.
Results Eighty patients (56 male, 24 female) presented
to a single institution between 1998 and 2005 with a
diagnosis of SCFE. The mean age of patients was 12.2
years at initial presentation (range 8.5–16). Forty-eight
patients (32 male, 16 female) presented with unilateral
SCFE, with 22 of the 48 patients having a BMI for-age
percentile C95 %. Thirty-two patients (24 male, 8 female)
presented with bilateral SCFE, with 29 of the 32 patients
having a BMI-for-age percentile C95 %. Patients with a
BMI-for-age C95 % had a significantly increased risk of
presentation with bilateral slips (OR 4.83; relative risk
[RR] 3.01; p\ 0.05]. All but one patient in this study
with bilateral SCFE or unilateral SCFE with subsequent
contralateral involvement had a BMI-for-age C85 % (44
out of 45 patients). Additionally, the overall risk of
developing bilateral SCFE until physeal closure with a
BMI-for-age C95 % was significantly increased
(OR 3.84; RR 2.02; p\ 0.05; number needed to treat
[NNT] 3.01).
Conclusions Previous work has established a relationship
between BMI and SCFE. The CDC BMI-for-age growth
charts more accurately measure obesity in the pediatric
population compared to BMI and are therefore a more
appropriate reference tool. This study demonstrates an
association between obesity measured by BMI-for-age
percentiles and SCFE. This study also demonstrates an
association between BMI-for-age and risk for bilateral
SCFE at presentation as well as overall incidence of
developing bilateral SCFE in the obese pediatric popula-
tion. By defining the at-risk population through BMI-for-
age, physicians can screen the pediatric patient population
and provide early strategies for therapeutic weight loss
which may reduce the incidence of SCFE.
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Introduction
Slipped capital femoral epiphysis (SCFE) is the most
common adolescent hip disorder, with an estimated
prevalence of 2.13–10.8 per 100,000 in the United States
[1, 2]. While most cases of SCFE are idiopathic, the fun-
damental etiology can be attributed to a combination of
mechanical, endocrine and genetic components. Over-
whelming shear stress across the physis ultimately results
in biomechanical failure characterized by anterior-cranial-
lateral movement of the proximal femoral metaphysis rel-
ative to the epiphysis [2–4].
Although SCFE may occur in children of healthy
weight, the disorder is commonly associated with obesity
[1–5]. Cadaver studies have suggested that increased
forces may lead to SCFE in these obese children [6]. It
has also been hypothesized that SCFE may be due to a
failure of the structural integrity of the physis secondary
to a genetic or acquired problem, such as that associated
with endocrine disorders [7–12].
The preferred treatment for SCFE is generally surgical
stabilization of the affected hip. In addition, at many
institutions surgeons may choose to perform prophylactic
pinning of the asymptomatic contralateral side [13–15].
As with any surgical procedure, internal fixation of SCFE
is not without risk and morbidity including possible
avascular necrosis and chondrolysis [16, 17]. As a result,
prophylactic pinning was traditionally performed only in
high-risk patients such as those with younger bone age at
presentation, renal failure, or endocrinopathies [18–22].
As more epidemiologic data become available, a number
of studies have suggested that prophylactic pinning may
be safer and preferable to observation, citing a high
prevalence of long-term osteoarthric sequela with missed
SCFE [14, 15, 23–26]. Nevertheless, controversy stills
exists regarding the advisability of prophylactic pinning
of the contralateral hip.
Body mass index (BMI) has also been suggested as a
risk factor for SCFE [5, 27, 28]. It has been consistently
demonstrated that patients presenting with SCFE have a
higher than average BMI, and that children with bilateral
SCFE have a higher BMI than children with unilateral
SCFE [1, 2, 6, 29–31]. Patients who present with unilat-
eral SCFE and progress to bilateral disease have also been
previously found to have a significantly greater BMI than
patients with unilateral SCFE who did not progress [28].
The recently developed BMI-for-age percentile has been
shown to more effectively evaluate obesity in the pediatric
population [29]. Although BMI is calculated in the same way
for children and adults, the criteria used to interpret the meaning
of BMI in children is different than adults as the amount of body
fat changes with age [30] (Fig. 1). For example, a 10-year-old
boy with a BMI of 23 would be considered obese (C95th per-
centile) while a 15-year-old boy with a BMI of 23 would be
considered healthy (5th–85th percentile) [31]. Methods for
evaluating obesity also depend on regional population dispar-
ities as demonstrated by differences in BMI calculations
between data collection references such as Must, Dallal and
Dietz, Cole et al., and Kuczmarski et al. [32–35]. Additionally,
studies such as those by Loder and colleagues demonstrate that
ethnicity differences must be considered when evaluating cer-
tain patient populations [36, 37].
The purpose of this study was to examine the relation-
ship between BMI-for-age and unilateral versus bilateral
presentation of SCFE as well to clinically follow these
patients until radiographic physeal closure to ascertain their
risk for future contralateral slip.
Materials and methods
This was a retrospective study of all patients with SCFE
presenting to one institution from 1998–2005. All charts and
radiographs were available for review. Height and weight at
Fig. 1 Body mass index-for-age percentiles [31]
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presentation were used to calculate BMI using the formula
BMI = weight (kg)/height2 (m2). The Center for Disease
Control (CDC) 2000 BMI-for-age growth charts were used
to calculate individual BMI-for-age percentiles. According
to the CDC growth charts, children with BMI-for-age levels
C95th percentile are considered obese and those between the
85th and 95th percentiles are considered overweight [29].
Patients were divided into one of three groups—unilateral
presentation, bilateral presentation, or unilateral presenta-
tion with subsequent contralateral slip. BMI-for-age per-
centile was calculated for each presentation.
The presence of SCFE was determined radiographically.
All radiographs were evaluated by both a board-certified
pediatric orthopedic surgeon as well as a board-certified
radiologist. In correlation with the physical examination
and history, criteria for diagnosis of slips were based on (1)
widening and irregularity of the physis, (2) evaluation of
Klein’s line or a Trethowan sign, and (3) discrepancy
between the head-shaft angle of the hips as seen on
anteroposterior and frog-leg lateral views of the pelvis. The
patients were followed up until complete closure of the
bilateral proximal femoral physes, which was considered
completion of the study. Statistical analysis for significant
differences between groups was performed using the
Kruskal–Wallis test for equality of populations. The level
of significance was set at 5 %. A logistic regression, con-
trolling for age and gender, was used to identify BMI-for-
age as a risk factor and to determine the significance of the
odds ratios (ORs) for the relevant categorical variables—
obese, overweight and healthy weight.
Results
Eighty patients (56 male, 24 female) presented to a single
institution between 1998 and 2005 with a diagnosis of
SCFE. The mean age of patients was 12.2 years at initial
presentation (range 8.5–16). The males were significantly
older with a mean age of 13.1 years (range 8.5–16) com-
pared to a mean age of 11.7 years (range 9–14) for females
(p\ 0.01). None of the children showed evidence of
endocrinopathy or renal failure. The mean duration of
follow-up was 2.2 years.
The mean BMI for all patients included in the study was
29.7 kg/m2 (range 19.0–47.5 kg/m2). Forty-eight patients
(32 male, 16 female) presented with unilateral SCFE, with
22 of the 48 patients having a BMI-for-age per-
centile C95 %. Thirty-two patients (24 male, 8 female)
presented with bilateral SCFE, with 29 of the 32 patients
having a BMI-for-age percentile C95 %. Thirteen patients
(7 male, 6 female) developed a subsequent contralateral
slip, with 10 of the 13 patients having a BMI-for-age
percentile C95 % (Fig. 2).
Patients with a BMI-for-age C95 % represented 63 %
of patients with unilateral SCFE (22/35), 91 % of patients
with bilateral SCFE (29/32), and 77 % of patients who
developed a contralateral slip (10/13). Patients with a BMI-
for-age between 85 and 95 % represented 23 % of patients
with unilateral SCFE (8/35), 9 % of patients with bilateral
SCFE (3/32), and 15 % of patients who developed a con-
tralateral slip (2/13) (Table 1).
Sixty-three percent of patients with a BMI-for-
age C95 % presented with a bilateral SCFE or presented
with unilateral SCFE and developed a subsequent con-
tralateral SCFE. All but one patient in this study with
bilateral SCFE or unilateral SCFE with subsequent con-
tralateral involvement had a BMI-for-age C85 % (44 out
of 45 patients).
Patients with a BMI-for-age C95 % had a significantly
increased risk of presentation with bilateral slips (OR 4.83;
RR 3.01; p\ 0.05]. There was no significant difference in
the development of future contralateral slip (OR 1.97;
RR 1.67; p = 0.38) when isolating patients who presented
with unilateral SCFE and went on to develop bilateral
pathology. The overall risk of developing bilateral SCFE































Fig. 2 Unilateral, bilateral, and subsequent SCFE by BMI-for-age
percentile
Table 1 Distribution of patients based on BMI-for-age and diagnosis
of SCFE
BMI-for-age Unilateral Unilateral?a Bilateral
\85 % 5 1 0
85–95 % 8 2 3
[95 % 22 10 29
Totals 35 13 32
a Unilateral? represents the group of patients that initially presented
with unilateral SCFE and subsequently developed SCFE in the con-
tralateral hip
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was significantly increased (OR 3.84; RR 2.02; p\ 0.05).
The number to be treated (NNT) was 3.01, suggesting that
pinning all hips in patients with a BMI-for-age [95 %
would mean pinning three hips in order to prevent one hip
from progression to bilateral slips. Patients with a BMI-for-
age between 85 and 95 % did not have a significantly
increased risk of presentation with bilateral slips (OR 4.33;
RR 3.50; p = 0.36) or development of future contralateral
slip (OR 1.25; RR 1.20; NNT 30; p = 0.87) compared to
individuals with a BMI-for-age\ 85 %.
Discussion and conclusion
Although the exact etiology of SCFE remains unproven,
many previous investigators have suggested an association
with obesity and possible increased shear stress across the
physis leading to an increased incidence of SCFE in this
population [6, 7, 10]. The results of this study support this
hypothesis as the majority of patients in this study were
classified as overweight or obese. Previous work has estab-
lished a relationship between BMI and SCFE [1, 27, 28, 38].
This study uses the CDC BMI-for-age growth charts to more
accurately measure obesity in the pediatric population
compared to BMI. However, the CDC reference is just one
way of calculating BMI-for-age; although it covers a large
sampling of representative populations, it is not all-inclusive.
The CDC references for the United States were based on data
collected from European Americans, African Americans and
Mexican Americans sampled between 1988 and 1994 in the
NHANES III study. When compared to other models it
demonstartes an increased proportion of the population in the
overweight and obesity categories [35, 39].
This study demonstrates an association between obesity
as measured by BMI-for-age percentiles and SCFE. This
study also elucidates an association between BMI-for-age
and risk for bilateral SCFE both at initial presentation and
throughout the remaining growth period. While there was
no significant association between BMI-for-age and sub-
sequent contralateral slip after initial presentation, our
study was likely underpowered to prove this given the
smaller sub-group size. If the assumption was made that all
patients with bilateral SCFE at initial presentation at some
point in their clinical history had unilateral SCFE and then
developed bilateral pathology, the adjusted calculations
would then indicate a statistically signficant correlation
between BMI and SCFE.
In addition to larger long-term prospective studies, fur-
ther work is needed to establish the effect of weight
reduction on the incidence of future contralateral slips in
this population. As suggested by Loder et al., physiologic
or bone age is less variable than the chronologic age when
discussing risk for SCFE and this may be one of the
limitations of our study [40]. Furthermore, as this is an
observational study continuous variables, such as age at
onset and relation to peak height velocity, are possible
cofounding factors during OR analysis.
The prevalence of bilateral involvement in this study is
also consistent with previously published reports of an
18–63 % prevalence of bilateral disease, with 40 % (32/80)
of patients presenting with bilateral SCFE in this study [23,
37, 41]. This study also demonstrates that patients with
bilateral SCFE had a significantly higher BMI-for-age than
children with unilateral SCFE. Patients who presented with
unilateral SCFE who progressed to bilateral disease also
had a significantly higher BMI-for-age than patients with
unilateral disease who did not progress.
Patients with a BMI-for-age C95 % are at a significantly
increased risk of developing SCFE. If clinically correlated,
obese patients warrant a high index of suspicion for bilateral
disease given their increased presentation with bilateral SCFE
and propensity for future development of a contralateral slip.
This study suggests that strong consideration should be given to
prophylactic stabilization of the contralateral hip in patients
with SCFE presenting with a BMI-for-age C95 %. In addition,
by defining the at-risk population through BMI-for-age,
physicians can screen the pediatric patient population and
provide early strategies for therapeutic weight loss which may
reduce the incidence of SCFE.
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